Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

Rhea-AI Summary

Agios Pharmaceuticals, Inc. will present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024. The presentation will focus on the company's pioneering therapies for rare diseases in the field of cellular metabolism.

CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the company is scheduled to present at the TD Cowen 44^th Annual Health Care Conference on Monday, March 4, 2024, at 2:10 p.m. ET.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.

About Agios
Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for this rare, lifelong, debilitating hemolytic anemia. Building on the company's deep scientific expertise in classical hematology and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, MDS-associated anemia and phenylketonuria (PKU). In addition to its clinical pipeline, Agios is advancing a preclinical TMPRSS6 siRNA as a potential treatment for polycythemia vera. For more information, please visit the company’s website at www.agios.com.

Contacts:

Investor Contact
Chris Taylor, VP, Investor Relations and Corporate Communications
Agios Pharmaceuticals
IR@agios.com

Media Contact
Dan Budwick
1AB
dan@1abmedia.com

 

FAQ

When is Agios Pharmaceuticals, Inc. presenting at the TD Cowen 44th Annual Health Care Conference?

Agios Pharmaceuticals, Inc. is scheduled to present at the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024, at 2:10 p.m. ET.

What is the focus of Agios Pharmaceuticals, Inc.'s presentation at the conference?

The presentation will focus on Agios Pharmaceuticals, Inc.'s pioneering therapies for rare diseases in the field of cellular metabolism.

Where can the live webcast of Agios Pharmaceuticals, Inc.'s presentation be accessed?

The live webcast of the presentation can be accessed under 'Events & Presentations' in the Investors section of the company's website at www.agios.com.

How long will the webcast replay be available on Agios Pharmaceuticals, Inc.'s website?

A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.